JEWEL MAEHLER: Open Payments
NPI 1194584557 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 19 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $104 · 2025 $469
Food & beverage: $469
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $180 |
| Lilly USA, LLC | 6 | $96 |
| Novo Nordisk Inc | 5 | $80 |
| Exact Sciences Corporation | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: BREZTRI, MOUNJARO, Ozempic, Cologuard Collection Kit, The Cologuard Plus Collection Kit, REXULTI, Rybelsus, GARDASIL 9.
Industry payments across LA — which companies pay providers there.
